Prescription drug · NDA
Oxaprozin NDC 70512-787
Oxaprozin 300 mg/1 · Capsule · Oral · SOLA Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70512-787-60 | 70512078760 | 60 CAPSULE in 1 BOTTLE (70512-787-60)Marketed from Dec 3, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxaprozin
- Generic name (nonproprietary)
- oxaprozin
- Active ingredients
- Oxaprozin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- SOLA Pharmaceuticals, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 217927
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 70512-787_450f5941-7f11-42fe-e063-6394a90a4803SPL ID 450f5941-7f11-42fe-e063-6394a90a4803SPL set ID 450f5941-7f10-42fe-e063-6394a90a4803RxCUI 2668162UNII MHJ80W9LRBUPC 0370512787608
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470512078760followed by a unit qualifier and the quantityPackage 70512-0787-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
OXAPROZIN is indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis OXAPROZIN CAPSULES is a non-steroidal anti-inflammatory drug indicated for: Relief of signs and symptoms of Osteoarthritis (OA) (1) Relief of signs and symptoms of Rheumatoid Arthritis (RA) (1) Relief of signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) (1)
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 217927
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Coxantooxaprozin | Oxaprozin 300 mg/1 | CapsuleOral | SOLA Pharmaceuticals, LLC | 70512-814 |